CME Group Stock Drops 12% in 11 Months Despite Record Revenue and Data Growth
Key Facts
In a move highlighting the divergence between operational success and market performance, CME Group reported record Q2 2026 results fueled by exceptional growth in non-trading services. The company achieved total revenue of $1.71 billion, bolstered by a surge in Market Data revenue exceeding 20% year-over-year, while adjusted earnings per share reached $2.99 with a robust operating margin of 69.5%.
Despite these record figures and the distribution of $1.2 billion to shareholders, the stock faces significant pressure, having declined nearly 12% over the past 11 months and underperforming the S&P 500.
Traders are now watching for potential support levels after the stock fluctuated between $235.01 and $255.11 in recent sessions. Looking ahead, market participants are monitoring global risk appetite following recent macroeconomic catalysts, including Malaysia's 5.8% GDP growth and the EU CPI decline to 2.8% as of July 17, 2026.